Salt Lake City, UT. , May 08, 2018 -- Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-seven cents ($.27) per share of common stock payable on July 6, 2018 to shareholders of record at the close of business on June 15, 2018. This is a 2% increase over the dividend declared in the same quarter of the prior year.
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD’s website at www.utahmed.com.
Contact: Utah Medical Products, Inc. Crystal Rios (801) 566-1200


Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Japan Earthquake Disrupts Auto and Chip Supply Chains
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
World game at war: why some European nations have threatened a World Cup boycott
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 



